With regard to clinical phenotypes, we found patients with IKZF1-mutated AML to show a significantly lower Hb and platelet count upon initial diagnosis, possibly corresponding to the suggested dysregulation of erythro- and megakaryopoiesis. The gene discussed is GSTM1; the disease is acute myeloid leukemia.